Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Roche appoints 454 Life Sciences president

Roche appoints 454 Life Sciences president

18th July 2011

Roche has announced that Dr Thomas Schinecker is to be appointed as president and lifecycle leader for sequencing at its 454 Life Sciences division.

Dr Schinecker, the current diagnostics general manager for the company's Swedish operations, will take up his new role on August 1st 2011 and will report to head of applied science Robert Yates.

He has been with Roche for more than eight years in a variety of key management positions and will utilise his organisational and operating skills to help develop 454 Life Sciences' pyrosequencing offering.

Mr Yates said Dr Schinecker's background in the oncology and diagnostics field make him well suited to the new role.

"We are very excited to announce Dr Thomas Schinecker as new president of 454 Life Sciences and look forward to expanding Roche's sequencing position as a leading genomics solution provider," he added.

Last month, the business unit launched the GS FLX Plus System, a new instrument capable of generating extra-long sequencing reads.ADNFCR-8000103-ID-800624921-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.